TY - JOUR
T1 - Superficial venous interventions
T2 - Assessing the risk of DVT
AU - Vedantham, Suresh
PY - 2008/4
Y1 - 2008/4
N2 - Objectives: Understand the potential consequences of deep vein thrombosis (DVT) in patients undergoing superficial venous interventions, the proper way to assess DVT risk in patients with superficial venous disease and the appropriate management of patients stratified by risk level. Methods: Review of published literature Results: Because DVTcan have major long-term consequences, DVT risk should be assessed as a routine part of the preprocedure evaluation of venous disease. Chronic venous disease may have multiple contributing factors amenable to treatment in both the superficial and deep venous systems. Conclusion: Superficial venous interventions should be deferred in patients at particularly high risk for DVT, but may be performed with appropriate countermeasures for DVT prophylaxis in patients at moderate risk.
AB - Objectives: Understand the potential consequences of deep vein thrombosis (DVT) in patients undergoing superficial venous interventions, the proper way to assess DVT risk in patients with superficial venous disease and the appropriate management of patients stratified by risk level. Methods: Review of published literature Results: Because DVTcan have major long-term consequences, DVT risk should be assessed as a routine part of the preprocedure evaluation of venous disease. Chronic venous disease may have multiple contributing factors amenable to treatment in both the superficial and deep venous systems. Conclusion: Superficial venous interventions should be deferred in patients at particularly high risk for DVT, but may be performed with appropriate countermeasures for DVT prophylaxis in patients at moderate risk.
KW - Deep vein thrombosis
KW - Post-thrombotic syndrome
KW - Saphenous vein ablation
UR - http://www.scopus.com/inward/record.url?scp=44949179508&partnerID=8YFLogxK
U2 - 10.1258/phleb.2007.007044
DO - 10.1258/phleb.2007.007044
M3 - Review article
C2 - 18453479
AN - SCOPUS:44949179508
SN - 0268-3555
VL - 23
SP - 53
EP - 57
JO - Phlebology
JF - Phlebology
IS - 2
ER -